Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuehong Deng

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Regulatory Toxicology and Pharmacology : RTP|December 6, 2016
The chronic hepatotoxicity assessment of the herbal formula Zishen Yutai pillXiaoyan Xing, Xuehong Deng, Jinjin Shi, et al.
The EMBO Journal|March 3, 2006
Mutual regulation of c-Jun and ATF2 by transcriptional activation and subcellular localizationHan Liu, Xuehong Deng, Y John Shyu, et al.
RSC Advances|May 11, 2022
Notoginsenoside R<sub>1</sub> prevents H9c2 cardiomyocytes apoptosis against hypoxia/reoxygenation <i>via</i> the ERs/PI3K/Akt pathwayGuang Li, Xiaoyan Xing, Yun Luo, et al.
Cancer Research|December 3, 2008
Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progressionXuehong Deng, Han Liu, Jiaoti Huang, et al.
The Prostate|July 18, 2025
PRMT5:MEP50 Are Mediators of Treatment-Induced Neuroendocrine Differentiation in Prostate CancerHye Seung Nam, Andrew Michael Asberry, Xuehong Deng, et al.
American Journal of Cancer Research|October 22, 2011
Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patientsXuehong Deng, Bennett D Elzey, Jean M Poulson, et al.
Iscience|December 30, 2019
PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair GenesJake L Owens, Elena Beketova, Sheng Liu, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
CDHu40: a novel marker gene set of neuroendocrine prostate cancer (NEPC)Sheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Scientific Reports|December 13, 2023
A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemiaRuilin Ding, Xuehong Deng, Longxia Chen, et al.
Briefings in Bioinformatics|September 25, 2024
CDHu40: a novel marker gene set of neuroendocrine prostate cancerSheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Regulatory Toxicology and Pharmacology : RTP|December 6, 2016
The chronic hepatotoxicity assessment of the herbal formula Zishen Yutai pillXiaoyan Xing, Xuehong Deng, Jinjin Shi, et al.
The EMBO Journal|March 3, 2006
Mutual regulation of c-Jun and ATF2 by transcriptional activation and subcellular localizationHan Liu, Xuehong Deng, Y John Shyu, et al.
RSC Advances|May 11, 2022
Notoginsenoside R<sub>1</sub> prevents H9c2 cardiomyocytes apoptosis against hypoxia/reoxygenation <i>via</i> the ERs/PI3K/Akt pathwayGuang Li, Xiaoyan Xing, Yun Luo, et al.
Cancer Research|December 3, 2008
Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progressionXuehong Deng, Han Liu, Jiaoti Huang, et al.
The Prostate|July 18, 2025
PRMT5:MEP50 Are Mediators of Treatment-Induced Neuroendocrine Differentiation in Prostate CancerHye Seung Nam, Andrew Michael Asberry, Xuehong Deng, et al.
American Journal of Cancer Research|October 22, 2011
Ionizing radiation induces neuroendocrine differentiation of prostate cancer cells in vitro, in vivo and in prostate cancer patientsXuehong Deng, Bennett D Elzey, Jean M Poulson, et al.
Iscience|December 30, 2019
PRMT5 Cooperates with pICln to Function as a Master Epigenetic Activator of DNA Double-Strand Break Repair GenesJake L Owens, Elena Beketova, Sheng Liu, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
CDHu40: a novel marker gene set of neuroendocrine prostate cancer (NEPC)Sheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Scientific Reports|December 13, 2023
A dose-escalation study of HP501, a highly selective URAT1 inhibitor, in male Chinese patients with hyperuricemiaRuilin Ding, Xuehong Deng, Longxia Chen, et al.
Briefings in Bioinformatics|September 25, 2024
CDHu40: a novel marker gene set of neuroendocrine prostate cancerSheng Liu, Hye Seung Nam, Ziyu Zeng, et al.
Pageof 3